|
參考文獻 郭承儒、陳怡偉、陳昌熙。 蟲蟲危機–以線蟲做為模式生物。科學發展 487:48-52,2013。 Barbut F, Corthier G, Charpak Y, 1996. Prevalence pathogenicity of Clostridium difficile in hospitalized patients. Arch Intern Med 156: 1449-56. Barbut F, Mastrantonio P, Delmee M, Brazier J, Kuijper E, Poxton I, 2007. Europeaned Study Group on Clostridium. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin Microbiol Infect 13: 1048-1057. Barth H, Pfeifer G, Hofmann F, Maier E, Benz R, Aktories K, 2001. Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J Biol Chem 276(14): 10670-6. Bartlett JG, Chang TW, Moon N, Onderdonk AB, 1978. Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am J Vet Res 39: 1525-1530. Bartlett JG, 1994. Clostridium difficile: history of its role as an enteric pathogen the current state of knowledge about the organism. Clin Infect Dis 18(4): 265-72. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT, Kuijper EJ, 2011. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377(9759): 63-73. Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC, 1999. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett 175(2): 261-6. Burns DA, Heap JT, Minton NP, 2010. The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type. Anaerobe 16(6): 618-22. Burns DA, Minton NP, 2011. Sporulation studies in Clostridium difficile. J Microbiol Methods. 87(2): 133-8. Centers for Disease Control and Prevention (CDC), 2013. Antibiotic Resistance Threats in the United States. Cerquetti M, Serafino A, Sebastianelli A, Mastrantonio P, 2002. Binding of Clostridium difficile to Caco-2 epithelial cell line and to extracellular matrix proteins. FEMS Immunol Med Microbiol 32(3): 211-8. Chen S, Sun C, Wang H, Wang J, 2015. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins. Toxins (Basel) 7(12): 5254-67. Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, Kelly CP, 2008. A mouse model of Clostridium difficile-associated disease. Gastroenterology 135(6): 1984-92. Chou TC, Chiu HC, Kuo CJ, Wu CM, Syu WJ, Chiu WT, Chen CS, 2013. Enterohaemorrhagic Escherichia coli O157:H7 Shiga-like toxin 1 is required for full pathogenicity and activation of the p38 mitogen-activated protein kinase pathway in Caenorhabditis elegans. Cell Microbiol 15(1): 82-97. Chung CH, Wu CJ, Lee HC, Yan JJ, Chang CM, Lee NY, Chen PL, Lee CC, Hung YP, Ko WC, 2010. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis. J Microbiol Immunol Infect 43(2): 119-25. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America. Infect Control Hosp Epidemiol 31(5): 431-55. Collins DA, Hawkey PM, Riley TV, 2013. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control 2(1): 21. Dubberke ER, Haslam DB, Lanzas C, Bobo LD, Burnham CA, Gröhn YT, Tarr PI, 2011. The Ecology and Pathobiology of Clostridium difficile Infections: An Interdisciplinary Challenge. Zoonoses Public Health 58(1): 4-20. Dubberke ER, Olsen MA, 2012. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 55(2): 88-92. Félix MA, Braendle C, 2010. The natural history of Caenorhabditis elegans. Curr Biol 20(22): R965-9. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC, 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391(6669): 806-11. Frisch C, Gerhard R, Aktories K, Hofmann F, Just I, 2003. The complete receptor-binding domain of Clostridium difficile toxin A is required for endocytosis. Biochem Biophys Res Commun 300(3): 706-11. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr, 1995. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 16(8): 459-77. Gerding DN, Johnson S, Rupnik M, Aktories K, 2014. Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes 5(1): 15-27. Gough E, Shaikh H, Manges AR, 2011. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 53(10): 994-1002. Greco A, Ho JG, Lin SJ, Palcic MM, Rupnik M, Ng KK, 2006. Carbohydrate recognition by Clostridium difficile toxin A. Nat Struct Mol Biol 13(5): 460-1. Guinane CM, Cotter PD, 2013. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 6(4): 295-308. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA, 2012. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 55: 216-223. Hall I, O'Toole E, 1935. Intestinal flora in newborn infants. Am J Dis Child 49: 390. Hecht G, Koutsouris A, Pothoulakis C, LaMont JT, Madara JL, 1992. Clostridium difficile toxin B disrupts the barrier function of T84 monolayers. Gastroenterology 102(2): 416-23. Hennequin C, Janoir C, Barc MC, Collignon A, Karjalainen T, 2003. Identification and characterization of a fibronectin-binding protein from Clostridium difficile. Microbiology 149(10): 2779-87. Hennequin C, Porcheray F, Waligora-Dupriet A, Collignon A, Barc M, Bourlioux P, Karjalainen T, 2001. GroEL (Hsp60) of Clostridium difficile is involved in cell adherence. Microbiology 147(1): 87-96. Hensgens MPM, Keessen EC, Squire MM, Riley TV, Koene MG, de Boer E, Lipman LJ, Kuijper EJ, 2012. Clostridium difficile infection in the community: a zoonotic disease. Clin Microbiol Infect 18: 635-645. Higgins D and Dworkin J, 2012. Recent progress in Bacillus subtilis sporulation. FEMS Microbiol Rev 36(1): 131-148. Honda H, Dubberke ER, 2014. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol 30: 54-62. Huber CA, Foster NF, Riley TV, Paterson DL, 2013. Challenges for Standardization of Clostridium difficile Typing Methods. J Clin Microbiol 51(9): 2810-4. Jank T, Aktories K, 2008. Structure and mode of action of clostridial glucosylating toxins: The ABCD model. Trends Microbiol 16(5): 222-9. Janoir C, Péchiné S, Grosdidier C, Collignon A, 2007. Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J Bacteriol 189(20): 7174-80. Joshi LT, Phillips DS, Williams CF, Alyousef A, Baillie L, 2012. The contribution of the spore to the ability of Clostridium difficile to adhere to surfaces. Appl. Environ Microbiol 78(21): 7671-9. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K, 1995. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 375(6531): 500-3. Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, Takakuwa H, Saikai T, Kobayashi K, Yamagishi T, Nakamura S, 2001. Colonisation and transmission of Clostridium difficile in healthy individuals examined by PCR ribotyping and pulsed-field gel electrophoresis. J Med Microbiol 50(8): 720-7. Keel K, Brazier JS, Post KW, Weese S, Songer JG, 2007. Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species. J Clin Microbiol 45(6): 1963-1964. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR, 2012. The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study. Am J Gastroenterol 107(1): 89-95. Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A, Minton NP, 2014. Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain. J Infect Dis 209(1): 83-6. Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM, 2011. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis 11: 194. Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gönczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL, 2015. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol 21(21): 6728-35. Kurz CL, Tan MW, 2004. Regulation of aging and innate immunity in C. elegans. Aging Cell 3(4): 185-93. Laaberki MH, Dworkin J, 2008. Death and survival of spore-forming bacteria in the Caenorhabditis elegans intestine. Symbiosis 46: 95-100. Labrousse A, Chauvet S, Couillault C, Kurz CL, Ewbank JJ, 2000. Caenorhabditis elegans is a model host for Salmonella typhimurium. Curr Bio 10(23): 1543-5. Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G, 2012. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8(10): e1002995. Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N, Mastroeni P, Scott P, Raisen C, Mottram L, Fairweather NF, Wren BW, Parkhill J, Dougan G, 2009. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun 77(9): 3661-9. Lemee L, Dhalluin A, Testelin S, Mattrat MA, Maillard K, Lemeland JF, Pons JL, 2004. Multiplex PCR targeting tpi (triose phosphate isomerase), tcdA (Toxin A), and tcdB (Toxin B) genes for toxigenic culture of Clostridium difficile. J Clin Microbiol (12): 5710-4. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, Farley MM, Holzbauer SM, Meek JI, Phipps EC, Wilson LE, Winston LG, Cohen JA, Limbago BM, Fridkin SK, Gerding DN, McDonald LC, 2015. Burden of Clostridium difficile infection in the United States. N Engl J Med 372(24): 825-834. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, René P, Monczak Y, Dascal A, 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353(23): 2442-9. McGee MD, Weber D, Day N, Vitelli C, Crippen D, Herndon LA, Hall DH, Melov S, 2011. Loss of intestinal nuclei and intestinal integrity inaging C. elegans. Aging Cell 10(4): 699-710. Mello CC, Kramer JM, Stinchcomb D, Ambros V, 1991. Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. EMBO J 10(12): 3959-70. Merrigan MM, Venugopal A, Roxas JL, Anwar F, Mallozzi MJ, Roxas BA, Gerding DN, Viswanathan VK, Vedantam G, 2013. Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficile. PLoS One 8(11): e78404. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003, 2006. Emerg Infect Dis 12: 409-415. Norman KN, Harvey RB, Scott HM, Hume ME, Andrews K, Brawley AD, 2009. Varied prevalence of Clostridium difficile in an integrated swine operation. Anaerobe 15(6): 256-60. O'Neill G, Adams JE, Bowman RA, Riley TV, 1993. A molecular characterization of Clostridium difficile isolates from humans, animals and their environments. Epidemiol Infect 111(2): 257-264. Ozaki E, Kato H, Kita H, Karasawa T, Maegawa T, Koino Y, Matsumoto K, Takada T, Nomoto K, Tanaka R, Nakamura S, 2004. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J Med Microbiol 53(2): 167-72. Paredes-Sabja D, Bond C, Carman RJ, Setlow P, Sarker MR, 2008. Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD). Microbiology 154(8): 2241-50. Paredes-Sabja D, Shen A, Sorg JA, 2014. Clostridium difficile spore biology: sporulation, germination, and spore structural proteins. Trends Microbiol 22(7): 406-16. Persson S, Torpdahl M, Olsen KE, 2008. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect (11): 1057-64. Pothoulakis C, Lamont JT, 2001. Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins. Am J Physiol Gastrointest Liver Physiol 280: G178-183. Prohaska JV, 1959. Pseudomembranous enterocolitis; the experimental induction of the disease with Staphylococcus aureus and its enterotoxin. AMA Arch Surg 79: 197-206. Pruitt RN, Chambers MG, Ng KK, Ohi MD, Lacy DB, 2010. Structural organization of the functional domains of Clostridium difficile toxins A and B. Proc Natl Acad Sci U S A 107(30): 13467-72. Qin J., Li R, Raes J, Arumugam M, Burgdorf K, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J, Bork P, Ehrlich SD, Wang J, 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285): 59-65. Riegler M, Sedivy R, Pothoulakis C, Hamilton G, Zacherl J, Bischof G, Cosentini E, Feil W, Schiessel R, LaMont JT, 1995. Clostridium difficile Toxin B Is More Potent than Toxin A in Damaging Human Colonic Epithelium In Vitro. J Clin Invest 95(5): 2004-11. Rodriguez C, Van Broeck J, Taminiau B, Delmée M, Daube G, 2016. Clostridium difficile infection: Early history, diagnosis and molecular strain typing methods. Microb Pathog 97: 59-78. Rupnik M, Janezic S, 2016. An Update on Clostridium difficile Toxinotyping. J Clin Microbiol 54(1): 13-8. Schwan C, Kruppke AS, Nölke T, Schumacher L, Koch-Nolte F, Kudryashev M, Stahlberg H, Aktories K, 2014. Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence. Proc Natl Acad Sci U S A 111(6): 2313-8. Songer JG, Post KW, Larson DJ, Jost BH, Glock RD, 2000. Infection of neonatal swine with Clostridium difficile. Swine Health Prod 8(4): 185-189. Songer JG, 2004. The emergence of Clostridium difficile as a pathogen of food animals. Anim Health Res Rev 5(2): 321-6. Spigaglia P, Barketi-Klai A, Collignon A, Mastrantonio P, Barbanti F, Rupnik M, Janezic S, Kansau I, 2013. Surface-layer (S-layer) of human and animal Clostridium difficile strains and their behaviour in adherence to epithelial cells and intestinal colonization. J Med Microbiol 62(9): 1386-93. Stein LD, Bao Z, Blasiar D, Blumenthal T, Brent MR, Chen N, Chinwalla A, Clarke L, Clee C, Coghlan A, Coulson A, D'Eustachio P, Fitch DH, Fulton LA, Fulton RE, Griffiths-Jones S, Harris TW, Hillier LW, Kamath R, Kuwabara PE, Mardis ER, Marra MA, Miner TL, Minx P, Mullikin JC, Plumb RW, Rogers J, Schein JE, Sohrmann M, Spieth J, Stajich JE, Wei C, Willey D, Wilson RK, Durbin R, Waterston RH, 2003. The genome sequence of Caenorhabditis briggsae: a platform for comparative genomics. PLoS Biol 1(2): E45. Sunenshine RH, McDonald LC, 2006. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleve Clin J Med 3(2): 187-97. Tan MW, Rahme LG, Sternberg JA, Tompkins RG, Ausubel FM, 1999. Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc Natl Acad Sci U S A 96(5): 2408-13. Tasteyre A, Barc MC, Collignon A, Boureau H, Karjalainen T, 2001. Role of FliC and FliD Flagellar Proteins of Clostridium difficile in Adherence and Gut Colonization. Infect Immun 69(12): 7937-40. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ, 2013. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med Jan 368(5): 407-15. von Eichel-Streiber C, Boquet P, Sauerborn M, Thelestam M, 1996. Large clostridial cytotoxins-a family of glycosyltransferases modifying small GTP-binding proteins. Trends Microbiol 4(10): 375-82. Voth DE, Ballard JD, 2005. Clostridium difficile Toxins: Mechanism of Action and Role in Disease. Clin Microbiol Rev 18(2): 247-63. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, Shine B, Oakley S, O'Connor L, Finney J, Vaughan A, Crook DW, Wilcox MH, Peto TE, 2013. Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis 56(11): 1589-600. Yun B, Oh S, Song M, Hong YS, Park S, Park DJ, Griffiths MW, Oh S, 2015. Inhibitory Effect of Epigallocatechin Gallate on the Virulence of Clostridium difficile PCR Ribotype 027. J Food Sci 80(12): M2925-31. Zhang Y, Lu H, Bargmann CI, 2005. Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans. Nature 438(7065): 179-84. Zilberberg MD, Shorr AF, Kollef MH, 2008. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 14: 929-931.
|